Endpoints News
Grow Therapy raises $150M Read in browser
Endpoints News
Thursday, 5 March 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
Drug Discovery Day 2026
AI-driven drug discovery is already reshaping pipelines. But algorithms alone won’t get a drug to the clinic. Join us for a free virtual program — then continue the conversation at an in-person only fireside chat and happy hour in Boston. Reserve your spot.
Dispatch from SF
I’m back from a quick trip to San Francisco, and I’ve come home feeling like healthcare’s going through possibly the biggest transformation I’ve seen. 
I spent most of my day yesterday at Lux Capital’s Health x Intelligence forum. Here are some of my initial impressions straight from my notebook: 
  • Tone shift: It felt like the healthcare industry has moved from AI is going to happen to AI is happening right now.
  • Changing economics: Commure CEO Tanay Tandon said on a panel that the General Catalyst-backed company is taking over AI-powered services such as  revenue cycle management for free at General Catalyst-owned health system Summa Health.
  • Quote of the day: “AI is moving at the speed of desperation,” Shantanu Nundy, advisor on AI, office of the commissioner at FDA, said on a panel about AI’s role in drug discovery and development. 
  • Non-AI-related buzzword of the day: “Chinese peptides.” Biohacking is still in!
  • OpenEvidence has some major pull. Despite the $12 billion startup not appearing directly on a panel, it came up at least twice. Thrive Capital partner Nworah Ayogu mentioned he passed on investing in the company’s Series A because he initially wasn’t convinced clinicians would use the medical search engine. Thrive went on to invest in the company’s Series B.
  • Most SF moment: Taking my first Waymo, if only to understand the metaphors for how AI might be used (with varying levels of human supervision) inside clinical care.
  • Speaking of clinical AI: I moderated a panel that got at how close we are to closed-loop AI in healthcare (that is, no humans involved in delivering care). It’s… closer than I would’ve thought.
  • The question I’m left with: Will there be a group of digital health companies that get left behind as healthcare goes through its AI transformation?
- Lydia
Here’s what’s new
How hospitals have moved beyond experimenting with AI
Hos­pi­tals are mov­ing from ex­per­i­ment­ing with AI to jus­ti­fy­ing their cost, hos­pi­tal lead­ers said.

Implementing the technology has grown into a strategic priority for hospitals’ board members in recent years, rather than a side quest for their IT departments, panelists leading AI initiatives at large health systems said at Cornell University’s Health Tech Summit in New York on Tuesday. 
Coast to Coast
An image of a panel happening at San Francisco's Exploratorium as part of Lux Capital's Health x AI event and a panel at Cornell University’s Health Tech Summit in New York.
Ngai and I spent quite a lot of time this week listening to panels in New York and San Francisco, bringing you some real cross-country health tech coverage!
This week in health Тech
Grow Therapy’s $150 million Series D values the mental health company at $3 billion, Bloomberg reports.
Cigna’s longtime CEO David Cordani is retiring on July 1. The health insurer named Brian Evanko, its president and chief operating officer, to succeed him. Cordani will become executive chairman.
Healthcare navigation company Quantum Health bought CirrusMD, a startup that allows patients to connect with doctors via chat. The deal comes after Quantum bought data analytics firm Embold Health last year.
Editor’s note: We corrected our story from Tuesday on Strive Pharmacy and its plans around a GLP-1 pill. Read the updated piece here.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times